Ahead of Presidential Election, Deal Volume Declines In October 2024
Activity in the healthcare industry slowed down in October 2024, but an increase in certain sectors has left investors feeling hopeful for the coming months. In October 2024, 144 healthcare transactions were reported, a notable decrease from both October 2023, when 189 deals were announced, and September 2024, when 161 deals were reported. It is important to note that these numbers are preliminary findings for the month, and more deals may be added to the statistics as companies continue to announce transactions. The most active sector in October was Other Services with 44 transactions, or approximately 31% of the announced healthcare deals. This is virtually the same as October 2023... Read More »Healthcare M&A Activity in Q3 Stabilizes
Despite all the headwinds straining the healthcare M&A market, deal activity stabilized in the third quarter of 2024, according to preliminary results in the LevinPro HC database. With 489 deals on the books in the last week of September, we saw only a marginal decline in activity compared with the second quarter of 2024 and year-over-year numbers. From April to June, there were 499 deals, and in Q3:23, activity reached 516 deals. Disclosed spending followed a similar trend to quarterly deal volumes, which is not always the case. Announced prices hit approximately $44 billion in Q3:24, a 7% decline compared to the second quarter ($47.4 billion) but a 7% year-over-year increase... Read More »
Most Active States for Healthcare Services M&A in 2024 (So Far)
As the healthcare industry continues to evolve, mergers and acquisitions (M&As) have become a strategic tool for providers to expand their reach, enhance services and improve efficiency. This year, certain states have emerged as particularly active hubs for healthcare services M&A. The healthcare services sectors included in this report include Behavioral Health Care, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Physician Medical Groups, Rehabilitation and Other Services (a mix of companies providing ancillary healthcare services, or those relating to healthcare). This analysis examines the most active U.S. states and regions... Read More »
Earnings Week in Review: Healthcare Giants Navigate Growth and Hurdles
We’re taking a look at some of the major companies reporting earnings in the week of July 15-July 19, across a variety of sectors. UnitedHealth Group and Novartis showcased strong growth, while Johnson & Johnson and Elevance Health presented more mixed results. Abbott Laboratories also reported solid results, driven by its medical devices segment, while facing challenges in its diagnostics business due to waning COVID-19 testing demand. This week’s earnings reports offer insights into the broader healthcare industry’s performance and future trajectory. UnitedHealth Group UnitedHealth Group (UHG) demonstrated a significant turnaround in its second quarter of 2024, posting a... Read More »
Private Equity M&A Activity in Healthcare Rises in Q2:24
Private equity (PE) investment has continued to play a substantial role in the healthcare M&A market. In the second quarter of 2024, there were 186 deals completed by PE companies or their sponsored companies (PE buyers, collectively), or approximately 38% of all the 496 announced healthcare deals, according to new data captured in the LevinPro HC database. This is a 24% increase from the first quarter of 2024 when 150 acquisitions from PE buyers were announced. Activity in Q2:24 represents a 17% decrease from Q2:23 when 224 PE buyer transactions were reported. In Q2:24, 10 transactions with a PE buyer had a disclosed price. The ten deals totaled more than $5.49 billion in announced... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
